title: Cyclin E1 controls proliferation of hepatic stellate cells and is essential for liver fibrogenesis in mice.
abstract: Liver fibrogenesis is associated with the transition of quiescent hepatocytes and hepatic stellate cells (HSCs) into the cell cycle. Exit from quiescence is controlled by E-type cyclins (cyclin E1 [CcnE1] and cyclin E2 [CcnE2]). Thus, the aim of the current study was to investigate the contribution of E-type cyclins for liver fibrosis in man and mice. Expression of CcnE1, but not of its homolog, CcnE2, was induced in fibrotic and cirrhotic livers from human patients with different etiologies and in murine wild-type (WT) livers after periodical administration of the profibrotic toxin, CCl(4). To further evaluate the potential function of E-type cyclins for liver fibrogenesis, we repetitively treated constitutive CcnE1(-/-) and CcnE2(-/-) knock-out mice with CCl(4) to induce liver fibrosis. Interestingly, CcnE1(-/-) mice were protected against CCl(4)-mediated liver fibrogenesis, as evidenced by reduced collagen type I α1 expression and the lack of septum formation. In contrast, CcnE2(-/-) mice showed accelerated fibrogenesis after CCl(4) treatment. We isolated primary HSCs from WT, CcnE1(-/-), and CcnE2(-/-) mice and analyzed their activation, proliferation, and survival in vitro. CcnE1 expression in WT HSCs was maximal when they started to proliferate, but decreased after the cells transdifferentiated into myofibroblasts. CcnE1(-/-) HSCs showed dramatically impaired survival, cell-cycle arrest, and strongly reduced expression of alpha smooth muscle actin, indicating deficient HSC activation. In contrast, CcnE2-deficient HSCs expressed an elevated level of CcnE1 and showed enhanced cell-cycle activity and proliferation, compared to WT cells.
  
  
  CONCLUSIONS
  CcnE1 and CcnE2 have antagonistic roles in liver fibrosis. CcnE1 is indispensable for the activation, proliferation, and survival of HSCs and thus promotes the synthesis of extracellular matrix and liver fibrogenesis.
authors.affiliation: Department of Medicine III, University Hospital, RWTH Aachen, Aachen, Germany.
authors.forename: Yulia A
authors.initials: YA
authors.lastname: Nevzorova
authors.forename: Jörg-Martin
authors.initials: JM
authors.lastname: Bangen
authors.forename: Wei
authors.initials: W
authors.lastname: Hu
authors.forename: Ute
authors.initials: U
authors.lastname: Haas
authors.forename: Ralf
authors.initials: R
authors.lastname: Weiskirchen
authors.forename: Nikolaus
authors.initials: N
authors.lastname: Gassler
authors.forename: Sebastian
authors.initials: S
authors.lastname: Huss
authors.forename: Frank
authors.initials: F
authors.lastname: Tacke
authors.forename: Piotr
authors.initials: P
authors.lastname: Sicinski
authors.forename: Christian
authors.initials: C
authors.lastname: Trautwein
authors.forename: Christian
authors.initials: C
authors.lastname: Liedtke
mesh_terms: D000818:Animals; D049109:Cell Proliferation; D019927:Cyclin E / Q000502:physiology*; D055166:Hepatic Stellate Cells / Q000502:physiology*; D006801:Humans; D008103:Liver Cirrhosis / Q000473:pathology*; D008297:Male; D051379:Mice; D015513:Oncogene Proteins / Q000502:physiology*
chemical_list: D019927:Cyclin E; D015513:Oncogene Proteins; C568314:cyclin E1, mouse